leadf
logo-loader
viewConcarlo Holdings, LLC

Concarlo Holdings using technology to fight drug resistance issues in breast cancer

Concarlo Holdings LLC Chief Scientific Officer Stacy Blain sat down with Christine Corrado from Proactive Investors at the 11th Annual Biotech Showcase in San Francisco. The Brooklyn, New York, company uses patented technologies to combat drug resistance in the treatment of breast cancer.
 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Altiplano Metals receives exploitation permit at Maria Luisa which allows...

Altiplano Metals CEO Alastair McIntyre joined Steve Darling from Proactive to share news the company has announced the Chilean mining authority has approved their exploitation license on the Maria Luisa project is located in Chile. McIntyre telling Proactive this now allows the company to...

3 hours ago

2 min read